In fact, in mouse models of arthritis involving active immunization, such as collagen- or antigen-induced arthritis, the use of ST2 KO mice, injection of anti-ST2 antibodies or treatment with sST2 consistently led to decreased immune responses and severity of arthritis [18-21]. This evidence concerns the gene IL1RL1 and arthritic joint disease.